Redefining Disease Severity with Special Area Involvement and Reflecting on Treatment Patterns in a Real-World Psoriasis Population
Abstract Background The International Psoriasis Council (IPC) recommends an approach that considers body surface area (BSA), involvement in special areas, and treatment history for classifying patients as candidates for topical or systemic treatment. This study aimed to quantify the burden of psoria...
Saved in:
Main Authors: | Mary E. Horner (Author), Kate K. Orroth (Author), Junjie Ma (Author), Yinkang Duan (Author), Myriam Cordey (Author) |
---|---|
Format: | Book |
Published: |
Adis, Springer Healthcare,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Diabetes and obesity burden and improvements in cardiometabolic parameters in patients with psoriasis or psoriatic arthritis receiving apremilast in a real-world settingCapsule Summary
by: Cristi Cavanaugh, MHS, et al.
Published: (2024) -
Apremilast Adherence and Persistence in Patients with Psoriasis and Psoriatic Arthritis in the Telehealth Setting Versus the In-person Setting During the COVID-19 Pandemic
by: Ashis K. Das, et al.
Published: (2023) -
Correction: Apremilast Adherence and Persistence in Patients with Psoriasis and Psoriatic Arthritis in the Telehealth Setting Versus the In-person Setting During the COVID-19 Pandemic
by: Ashis K. Das, et al.
Published: (2023) -
Impact of psoriasis disease severity and special area involvement on patient-reported outcomes in the real world: an analysis from the CorEvitas psoriasis registry
by: Bruce Strober, et al.
Published: (2024) -
Characteristics and outcomes of patients with psoriasis treated with apremilast in the real-world in Austria - results the APPRECIATE study
by: Constanze Jonak, et al.
Published: (2023)